400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Cell Cycle / PLK / BI 2536
CAS No.: 755038-02-9
Synonyms: BI-2536
BI-2536 is a potent Plk1 inhibitor with IC50 of 0.83 nM, BI2536 shows 4- and 11-fold greater selectivity against Plk2 and Plk3 and also is a BRD4 inhibitor (IC50= 25 nM).
生物活性
靶点 | Bromodomain 4 IC50:25nM | PLK1 IC50:0.83nM |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00526149 | Breast Cancer ... more >> Endometrial Cancer Head and Neck Cancer Melanoma (Skin) Ovarian Cancer Sarcoma Collapse << | Phase 2 | Completed | - | Belgium ... more >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 Collapse << |
NCT00710710 | Pancreatic Neoplasms | Phase 2 | Completed | - | Austria ... more >> 1216.10.43001 Boehringer Ingelheim Investigational Site Wien, Austria Germany 1216.10.49013 Boehringer Ingelheim Investigational Site Celle, Germany 1216.10.49009 Boehringer Ingelheim Investigational Site Düsseldorf, Germany 1216.10.49007 Boehringer Ingelheim Investigational Site Essen, Germany 1216.10.49001 Boehringer Ingelheim Investigational Site Freiburg/Breisgau, Germany 1216.10.49005 Boehringer Ingelheim Investigational Site Hamburg, Germany 1216.10.49010 Boehringer Ingelheim Investigational Site Herne, Germany 1216.10.49008 Boehringer Ingelheim Investigational Site München, Germany 1216.10.49003 Boehringer Ingelheim Investigational Site Stuttgart, Germany 1216.10.49002 Boehringer Ingelheim Investigational Site Ulm, Germany Collapse << |
NCT00412880 | Carcinoma, Small Cell | Phase 2 | Completed | - | United States, Arkansas ... more >> 1216.11.007 Boehringer Ingelheim Investigational Site Fayetteville, Arkansas, United States United States, Illinois 1216.11.003 Boehringer Ingelheim Investigational Site Chicago, Illinois, United States 1216.11.006 Boehringer Ingelheim Investigational Site Evanston, Illinois, United States United States, Massachusetts 1216.11.002 Boehringer Ingelheim Investigational Site Boston, Massachusetts, United States United States, Missouri 1216.11.005 Boehringer Ingelheim Investigational Site St. Louis, Missouri, United States United States, North Carolina 1216.11.001 Boehringer Ingelheim Investigational Site Chapel Hill, North Carolina, United States United States, South Carolina 1216.11.011 Boehringer Ingelheim Investigational Site Charleston, South Carolina, United States 1216.11.010 Boehringer Ingelheim Investigational Site Greenville, South Carolina, United States United States, Washington 1216.11.012 Boehringer Ingelheim Investigational Site Seattle, Washington, United States Canada, Alberta 1216.11.009 Alberta Cancer Board Edmonton, Alberta, Canada Collapse << |
实验方案
技术信息
CAS号 | 755038-02-9 | 储存条件 |
|
|||||||||
分子式 | C28H39N7O3 | 运输 | 蓝冰 | |||||||||
分子量 | 521.65 | 别名 | BI-2536 | |||||||||
溶解度 |
|
动物实验配方 |
|
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
5637 | - | Growth Inhibition Assay | - | IC50=45.47 nM | 23792639 |
697 | - | Growth Inhibition Assay | - | IC50=0.01668 μM | SANGER |
697 | - | Growth Inhibition Assay | 24 h | IC50=2107.1 nM | 24519995 |
697 | - | Growth Inhibition Assay | 48 h | IC50=305.3 nM | 24519995 |
697 | - | Growth Inhibition Assay | 72 h | IC50=74.28 nM | 24519995 |
786-O | 5-80 nM | Growth Inhibition Assay | 96 h | suppresses the proliferation in a dose-dependent manner with IC50 values of 2 to 20 nM | 21642374 |
8505C | 0.1-100 nM | Growth Inhibition Assay | 72 h | EC50=3.2 nM | 19223553 |
8-MG-BA | - | Growth Inhibition Assay | - | IC50=0.05851 μM | SANGER |
A101D | - | Growth Inhibition Assay | - | IC50=0.03748 μM | SANGER |
A253 | - | Growth Inhibition Assay | - | IC50=0.08822 μM | SANGER |
A388 | - | Growth Inhibition Assay | - | IC50=0.02227 μM | SANGER |
A3-KAW | - | Growth Inhibition Assay | - | IC50=0.25341 μM | SANGER |
A498 | - | Growth Inhibition Assay | - | IC50=6.87192 μM | SANGER |
A498 | 5-80 nM | Growth Inhibition Assay | 96 h | suppresses the proliferation in a dose-dependent manner with IC50 values of 2 to 20 nM | 21642374 |
A4-Fuk | - | Growth Inhibition Assay | - | IC50=0.02218 μM | SANGER |
A704 | - | Growth Inhibition Assay | - | IC50=3.14194 μM | SANGER |
ACHN | 5-80 nM | Growth Inhibition Assay | 96 h | suppresses the proliferation in a dose-dependent manner with IC50 values of 2 to 20 nM | 21642374 |
ACN | - | Growth Inhibition Assay | - | IC50=0.00843 μM | SANGER |
ACT-1 | 0.1-100 nM | Growth Inhibition Assay | 72 h | EC50=5.4 nM | 19223553 |
ALL-PO | - | Growth Inhibition Assay | - | IC50=0.013 μM | SANGER |
ARH-77 | - | Growth Inhibition Assay | - | IC50=0.17379 μM | SANGER |
ATN-1 | - | Growth Inhibition Assay | - | IC50=0.06345 μM | SANGER |
AU565 | 0-100 nM | Growth Inhibition Assay | 72 h | inhibits the cell viability in a dose-dependent mannar | 22309939 |
BB30-HNC | - | Growth Inhibition Assay | - | IC50=0.06436 μM | SANGER |
BB49-HNC | - | Growth Inhibition Assay | - | IC50=9.42265 μM | SANGER |
BB65-RCC | - | Growth Inhibition Assay | - | IC50=0.10294 μM | SANGER |
BC-1 | - | Growth Inhibition Assay | - | IC50=0.22616 μM | SANGER |
BC-3 | - | Growth Inhibition Assay | - | IC50=0.09662 μM | SANGER |
BE-13 | - | Growth Inhibition Assay | - | IC50=0.0274 μM | SANGER |
Becker | - | Growth Inhibition Assay | - | IC50=0.03555 μM | SANGER |
BL-41 | - | Growth Inhibition Assay | - | IC50=0.04125 μM | SANGER |
BL-70 | - | Growth Inhibition Assay | - | IC50=0.02857 μM | SANGER |
BOKU | - | Growth Inhibition Assay | - | IC50=0.43792 μM | SANGER |
BT-474 | - | Growth Inhibition Assay | - | IC50=0.88854 μM | SANGER |
BT-474-M1 | 0-100 nM | Growth Inhibition Assay | 72 h | inhibits the cell viability in a dose-dependent mannar | 22309939 |
BV-173 | - | Growth Inhibition Assay | - | IC50=0.11243 μM | SANGER |
C2 | 1-1000 nM | Growth Inhibition Assay | 72 h | inhibits the cell proliferation in a dose-dependent manne | 21242189 |
C2BBe1 | - | Growth Inhibition Assay | - | IC50=11.3523 μM | SANGER |
C4-2 | - | Growth Inhibition Assay | - | IC50=8 nM | 25505174 |
C8166 | - | Growth Inhibition Assay | - | IC50=13.8303 μM | SANGER |
CA46 | - | Growth Inhibition Assay | - | IC50=2.75967 μM | SANGER |
Caki-1 | 5-80 nM | Growth Inhibition Assay | 96 h | suppresses the proliferation in a dose-dependent manner with IC50 values of 2 to 20 nM | 21642374 |
CAL-148 | - | Growth Inhibition Assay | - | IC50=0.14483 μM | SANGER |
CAL62 | 0.1-100 nM | Growth Inhibition Assay | 72 h | EC50=1.4 nM | 19223553 |
Calu-6 | - | Growth Inhibition Assay | - | IC50=0.09598 μM | SANGER |
CAS-1 | - | Growth Inhibition Assay | - | IC50=1.34231 μM | SANGER |
CB1117 | - | Growth Inhibition Assay | - | IC50=15.6 nM | 24204733 |
CB660 | - | Growth Inhibition Assay | - | IC50=6.4 nM | 24204733 |
CC-LP-1 | - | Growth Inhibition Assay | 72 h | IC50=5.84 nM | 21965739 |
CCRF-CEM | - | Growth Inhibition Assay | - | IC50=0.02543 μM | SANGER |
CC-SW-1 | - | Growth Inhibition Assay | 72 h | IC50=9.55 nM | 21965739 |
CEM | - | Growth Inhibition Assay | 24 h | IC50=52.18 nM | 24519995 |
CEM | - | Growth Inhibition Assay | 48 h | IC50=24.55 nM | 24519995 |
CEM | - | Growth Inhibition Assay | 72 h | IC50=5.42 nM | 24519995 |
CESS | - | Growth Inhibition Assay | - | IC50=0.01602 μM | SANGER |
CGTH-W-1 | - | Growth Inhibition Assay | - | IC50=0.60755 μM | SANGER |
CHP-126 | - | Growth Inhibition Assay | - | IC50=1.16199 μM | SANGER |
CHP-212 | 1-125 nM | Growth Inhibition Assay | 24-120 h | inhibits the cell proliferation in both time- and dose-dependent manne | 21169242 |
CMK | - | Growth Inhibition Assay | - | IC50=0.08225 μM | SANGER |
COLO-320-HSR | - | Growth Inhibition Assay | - | IC50=0.18154 μM | SANGER |
COLO-668 | - | Growth Inhibition Assay | - | IC50=0.45668 μM | SANGER |
COLO-684 | - | Growth Inhibition Assay | - | IC50=0.15721 μM | SANGER |
COLO-800 | - | Growth Inhibition Assay | - | IC50=40.0773 μM | SANGER |
COLO-824 | - | Growth Inhibition Assay | - | IC50=34.1006 μM | SANGER |
COLO-829 | - | Growth Inhibition Assay | - | IC50=6.33359 μM | SANGER |
CORL-23/P | - | Growth Inhibition Assay | - | IC50=4.38 ± 1.25 nM | 23962445 |
CORL-23/R | - | Growth Inhibition Assay | - | IC50=5.16 ± 1.83 nM | 23962445 |
COR-L279 | - | Growth Inhibition Assay | - | IC50=0.09556 μM | SANGER |
COR-L88 | - | Growth Inhibition Assay | - | IC50=0.14802 μM | SANGER |
CP66-MEL | - | Growth Inhibition Assay | - | IC50=0.31878 μM | SANGER |
CP67-MEL | - | Growth Inhibition Assay | - | IC50=0.67596 μM | SANGER |
CPC-N | - | Growth Inhibition Assay | - | IC50=0.06524 μM | SANGER |
CTB-1 | - | Growth Inhibition Assay | - | IC50=0.24493 μM | SANGER |
CTV-1 | - | Growth Inhibition Assay | - | IC50=0.05502 μM | SANGER |
D-247MG | - | Growth Inhibition Assay | - | IC50=0.73232 μM | SANGER |
D-263MG | - | Growth Inhibition Assay | - | IC50=0.94512 μM | SANGER |
D-336MG | - | Growth Inhibition Assay | - | IC50=0.61791 μM | SANGER |
D-502MG | - | Growth Inhibition Assay | - | IC50=7.9836 μM | SANGER |
Daoy | 1.875-240 nM | Growth Inhibition Assay | 72 h | IC50=5 nM | 22390279 |
Daudi | - | Growth Inhibition Assay | - | IC50=0.08256 μM | SANGER |
DB | - | Growth Inhibition Assay | - | IC50=3.25576 μM | SANGER |
DEL | - | Growth Inhibition Assay | - | IC50=0.05709 μM | SANGER |
DG-75 | - | Growth Inhibition Assay | - | IC50=0.08922 μM | SANGER |
DJM-1 | - | Growth Inhibition Assay | - | IC50=0.05142 μM | SANGER |
DMS-114 | - | Growth Inhibition Assay | - | IC50=0.07528 μM | SANGER |
DMS-153 | - | Growth Inhibition Assay | - | IC50=1.57674 μM | SANGER |
DMS-79 | - | Growth Inhibition Assay | - | IC50=7.04512 μM | SANGER |
DOHH-2 | - | Growth Inhibition Assay | - | IC50=0.17672 μM | SANGER |
DSH1 | - | Growth Inhibition Assay | - | IC50=0.38631 μM | SANGER |
DU145 | - | Growth Inhibition Assay | - | IC50∼60 nM | 23884428 |
DU-4475 | - | Growth Inhibition Assay | - | IC50=0.10407 μM | SANGER |
EB2 | - | Growth Inhibition Assay | - | IC50=12.6881 μM | SANGER |
EB-3 | - | Growth Inhibition Assay | - | IC50=0.61153 μM | SANGER |
ECC4 | - | Growth Inhibition Assay | - | IC50=6.82179 μM | SANGER |
EC-GI-10 | - | Growth Inhibition Assay | - | IC50=0.32987 μM | SANGER |
EGI-1 | - | Growth Inhibition Assay | 72 h | IC50=10.72 nM | 21965739 |
EHEB | - | Growth Inhibition Assay | - | IC50=0.71854 μM | SANGER |
EKVX | - | Growth Inhibition Assay | - | IC50=0.79073 μM | SANGER |
EM-2 | - | Growth Inhibition Assay | - | IC50=0.15467 μM | SANGER |
EoL-1-cell | - | Growth Inhibition Assay | - | IC50=0.11672 μM | SANGER |
ES1 | - | Growth Inhibition Assay | - | IC50=9.68956 μM | SANGER |
ES3 | - | Growth Inhibition Assay | - | IC50=13.9977 μM | SANGER |
ES4 | - | Growth Inhibition Assay | - | IC50=0.03463 μM | SANGER |
ES5 | - | Growth Inhibition Assay | - | IC50=21.7671 μM | SANGER |
ES6 | - | Growth Inhibition Assay | - | IC50=0.02881 μM | SANGER |
ES7 | - | Growth Inhibition Assay | - | IC50=19.5507 μM | SANGER |
ES8 | - | Growth Inhibition Assay | - | IC50=0.01494 μM | SANGER |
ETK-1 | - | Growth Inhibition Assay | - | IC50=0.02736 μM | SANGER |
EVSA-T | - | Growth Inhibition Assay | - | IC50=0.20312 μM | SANGER |
EW-1 | - | Growth Inhibition Assay | - | IC50=0.05837 μM | SANGER |
EW-13 | - | Growth Inhibition Assay | - | IC50=3.83417 μM | SANGER |
EW-16 | - | Growth Inhibition Assay | - | IC50=0.01336 μM | SANGER |
EW-24 | - | Growth Inhibition Assay | - | IC50=0.92002 μM | SANGER |
EW-3 | - | Growth Inhibition Assay | - | IC50=0.12893 μM | SANGER |
G166 | - | Growth Inhibition Assay | - | IC50=7.0 nM | 24204733 |
G7 | - | Growth Inhibition Assay | - | IC50=3.3 nM | 24204733 |
GAK | - | Growth Inhibition Assay | - | IC50=0.21189 μM | SANGER |
GB-1 | - | Growth Inhibition Assay | - | IC50=0.14526 μM | SANGER |
GBC | - | Growth Inhibition Assay | 72 h | IC50=14.78 nM | 21965739 |
GB-CL-1 | - | Growth Inhibition Assay | 72 h | IC50=5.22 nM | 21965739 |
GCIY | - | Growth Inhibition Assay | - | IC50=0.70363 μM | SANGER |
GDM-1 | - | Growth Inhibition Assay | - | IC50=0.33059 μM | SANGER |
GI-1 | - | Growth Inhibition Assay | - | IC50=0.01383 μM | SANGER |
GI-ME-N | - | Growth Inhibition Assay | - | IC50=0.07286 μM | SANGER |
GOTO | - | Growth Inhibition Assay | - | IC50=0.42118 μM | SANGER |
GR-ST | - | Growth Inhibition Assay | - | IC50=0.21488 μM | SANGER |
GT3TKB | - | Growth Inhibition Assay | - | IC50=0.02953 μM | SANGER |
H-1 | - | Growth Inhibition Assay | 72 h | IC50=9.54 nM | 21965739 |
HAL-01 | - | Growth Inhibition Assay | - | IC50=0.99872 μM | SANGER |
HC-1 | - | Growth Inhibition Assay | - | IC50=0.05597 μM | SANGER |
HCC1187 | - | Growth Inhibition Assay | - | IC50=3.78315 μM | SANGER |
HCC1599 | - | Growth Inhibition Assay | - | IC50=0.04258 μM | SANGER |
HCC2157 | - | Growth Inhibition Assay | - | IC50=0.84951 μM | SANGER |
HCC2218 | - | Growth Inhibition Assay | - | IC50=0.79131 μM | SANGER |
HCE-4 | - | Growth Inhibition Assay | - | IC50=0.02682 μM | SANGER |
HCE-T | - | Growth Inhibition Assay | - | IC50=0.16504 μM | SANGER |
HCT116p53(-/-) | 10-1000 nM | Growth Inhibition Assay | 24/48 h | inhibits cell proliferation completely at 25 nM | 22262171 |
HCT116p53(+/+) | 10-1000 nM | Growth Inhibition Assay | 24/48 h | inhibits cell proliferation completely at 25 nM | 22262171 |
HDLM-2 | - | Growth Inhibition Assay | - | IC50=0.37814 μM | SANGER |
HD-MY-Z | - | Growth Inhibition Assay | - | IC50=0.10856 μM | SANGER |
Hec50co | - | Growth Inhibition Assay | - | IC50=5 nM | 23146687 |
HEL | - | Growth Inhibition Assay | - | IC50=0.08668 μM | SANGER |
HeLa | 10-100 nM | Growth Inhibition Assay | 48 h | IC50=52.9 nM | 22080235 |
HeLa | 10-100 nM | Growth Inhibition Assay | 72 h | IC50=50.5 nM | 22080235 |
HH | - | Growth Inhibition Assay | - | IC50=0.21405 μM | SANGER |
HL-60 | - | Growth Inhibition Assay | - | IC50=1.99908 μM | SANGER |
HMC-1.1 | 1-1000 nM | Growth Inhibition Assay | 72 h | inhibits the cell proliferation in a dose-dependent manne | 21242189 |
HMC-1.2 | 1-1000 nM | Growth Inhibition Assay | 72 h | inhibits the cell proliferation in a dose-dependent manne | 21242189 |
HOP-62 | - | Growth Inhibition Assay | - | IC50=0.0242 μM | SANGER |
HR5 | 0-100 nM | Growth Inhibition Assay | 72 h | inhibits the cell viability in a dose-dependent mannar | 22309939 |
HT | - | Growth Inhibition Assay | - | IC50=0.13574 μM | SANGER |
HT-144 | - | Growth Inhibition Assay | - | IC50=0.0613 μM | SANGER |
HuH-28 | - | Growth Inhibition Assay | 72 h | IC50=11.19 nM | 21965739 |
Huh-7 | 1/10/100/1000 nM | Growth Inhibition Assay | 48 h | decreases the cell viability dose-dependently | 22745587 |
HUTU-80 | - | Growth Inhibition Assay | - | IC50=0.02624 μM | SANGER |
IA-LM | - | Growth Inhibition Assay | - | IC50=0.01688 μM | SANGER |
IMR-32 | 1-125 nM | Growth Inhibition Assay | 24-120 h | inhibits the cell proliferation in both time- and dose-dependent manne | 21169242 |
IMR-5 | - | Growth Inhibition Assay | - | IC50=0.05021 μM | SANGER |
IST-MEL1 | - | Growth Inhibition Assay | - | IC50=0.04442 μM | SANGER |
IST-MES1 | - | Growth Inhibition Assay | - | IC50=0.29238 μM | SANGER |
IST-SL1 | - | Growth Inhibition Assay | - | IC50=0.34914 μM | SANGER |
IST-SL2 | - | Growth Inhibition Assay | - | IC50=0.07004 μM | SANGER |
JAR | - | Growth Inhibition Assay | - | IC50=0.10925 μM | SANGER |
JiyoyeP-2003 | - | Growth Inhibition Assay | - | IC50=0.20477 μM | SANGER |
J-RT3-T3-5 | - | Growth Inhibition Assay | - | IC50=0.44878 μM | SANGER |
JURKAT | - | Growth Inhibition Assay | 24 h | IC50=416.66 nM | 24519995 |
JURKAT | - | Growth Inhibition Assay | 48 h | IC50=14.84 nM | 24519995 |
JURKAT | - | Growth Inhibition Assay | 72 h | IC50=3.65 nM | 24519995 |
JVM-2 | - | Growth Inhibition Assay | - | IC50=2.06135 μM | SANGER |
JVM-3 | - | Growth Inhibition Assay | - | IC50=1.47855 μM | SANGER |
K052 | - | Growth Inhibition Assay | - | IC50=0.11712 μM | SANGER |
K5 | - | Growth Inhibition Assay | - | IC50=0.26984 μM | SANGER |
K-562 | - | Growth Inhibition Assay | - | IC50=0.10858 μM | SANGER |
KALS-1 | - | Growth Inhibition Assay | - | IC50=0.02338 μM | SANGER |
KARPAS-299 | - | Growth Inhibition Assay | - | IC50=0.19241 μM | SANGER |
KARPAS-422 | - | Growth Inhibition Assay | - | IC50=0.25435 μM | SANGER |
KARPAS-45 | - | Growth Inhibition Assay | - | IC50=0.05358 μM | SANGER |
KB-3-1 | - | Growth Inhibition Assay | - | IC50=1.48 ± 0.53 nM | 23962445 |
KB-8-5-11 | - | Growth Inhibition Assay | - | IC50=5.01 ± 2.01 nM | 23962445 |
KB-C-1 | - | Growth Inhibition Assay | - | IC50=16.76 ± 4.51 nM | 23962445 |
KB-V1 | - | Growth Inhibition Assay | - | IC50=3.92 μM | 23593196 |
KB-V-1 | - | Growth Inhibition Assay | - | IC50=281.24 ± 31.57 nM | 23962445 |
KE-37 | - | Growth Inhibition Assay | - | IC50=0.02741 μM | SANGER |
Kelly | 1-125 nM | Growth Inhibition Assay | 24-120 h | inhibits the cell proliferation in both time- and dose-dependent manne | 21169242 |
KG1 | 1/10/100 nM | Growth Inhibition Assay | 72 h | inhibits the cell proliferation in both time- and dose-dependent manne | 19458358 |
KG-1 | - | Growth Inhibition Assay | - | IC50=40.8955 μM | SANGER |
KGN | - | Growth Inhibition Assay | - | IC50=0.08759 μM | SANGER |
KINGS-1 | - | Growth Inhibition Assay | - | IC50=0.1591 μM | SANGER |
KLE | - | Growth Inhibition Assay | - | IC50=0.52171 μM | SANGER |
KM12 | - | Growth Inhibition Assay | - | IC50=0.01348 μM | SANGER |
KM-H2 | - | Growth Inhibition Assay | - | IC50=0.06221 μM | SANGER |
KMOE-2 | - | Growth Inhibition Assay | - | IC50=0.35175 μM | SANGER |
KNS-42 | - | Growth Inhibition Assay | - | IC50=0.08161 μM | SANGER |
KNS-81-FD | - | Growth Inhibition Assay | - | IC50=0.81011 μM | SANGER |
KP-N-RT-BM-1 | - | Growth Inhibition Assay | - | IC50=0.13612 μM | SANGER |
KP-N-YS | - | Growth Inhibition Assay | - | IC50=0.04085 μM | SANGER |
KS-1 | - | Growth Inhibition Assay | - | IC50=0.06748 μM | SANGER |
KU812 | - | Growth Inhibition Assay | - | IC50=0.12044 μM | SANGER |
KURAMOCHI | - | Growth Inhibition Assay | - | IC50=0.02285 μM | SANGER |
KY821 | - | Growth Inhibition Assay | - | IC50=0.05632 μM | SANGER |
L-363 | - | Growth Inhibition Assay | - | IC50=0.11079 μM | SANGER |
L-428 | - | Growth Inhibition Assay | - | IC50=0.18813 μM | SANGER |
L-540 | - | Growth Inhibition Assay | - | IC50=0.10708 μM | SANGER |
LAMA-84 | - | Growth Inhibition Assay | - | IC50=0.13187 μM | SANGER |
LAN-6 | - | Growth Inhibition Assay | - | IC50=0.31572 μM | SANGER |
LB1047-RCC | - | Growth Inhibition Assay | - | IC50=0.2441 μM | SANGER |
LB2241-RCC | - | Growth Inhibition Assay | - | IC50=0.52525 μM | SANGER |
LB2518-MEL | - | Growth Inhibition Assay | - | IC50=0.49703 μM | SANGER |
LB373-MEL-D | - | Growth Inhibition Assay | - | IC50=0.39197 μM | SANGER |
LB647-SCLC | - | Growth Inhibition Assay | - | IC50=0.03195 μM | SANGER |
LB771-HNC | - | Growth Inhibition Assay | - | IC50=0.05979 μM | SANGER |
LB831-BLC | - | Growth Inhibition Assay | - | IC50=0.08561 μM | SANGER |
LB996-RCC | - | Growth Inhibition Assay | - | IC50=1.08051 μM | SANGER |
LC-1F | - | Growth Inhibition Assay | - | IC50=0.62592 μM | SANGER |
LC-2-ad | - | Growth Inhibition Assay | - | IC50=0.01093 μM | SANGER |
LC4-1 | - | Growth Inhibition Assay | - | IC50=0.19502 μM | SANGER |
LNCaP | - | Growth Inhibition Assay | - | IC50=91.3 nM | 25505174 |
LNCaP | - | Growth Inhibition Assay | - | IC50∼75 nM | 23884428 |
LNCaP-Clone-FGC | - | Growth Inhibition Assay | - | IC50=41.9017 μM | SANGER |
LOUCY | - | Growth Inhibition Assay | - | IC50=0.0205 μM | SANGER |
LOXIMVI | - | Growth Inhibition Assay | - | IC50=0.16949 μM | SANGER |
LP-1 | - | Growth Inhibition Assay | - | IC50=0.1424 μM | SANGER |
LS-1034 | - | Growth Inhibition Assay | - | IC50=0.38954 μM | SANGER |
LS-123 | - | Growth Inhibition Assay | - | IC50=0.15917 μM | SANGER |
LS-411N | - | Growth Inhibition Assay | - | IC50=0.01407 μM | SANGER |
LS-513 | - | Growth Inhibition Assay | - | IC50=0.67259 μM | SANGER |
LU-134-A | - | Growth Inhibition Assay | - | IC50=0.08708 μM | SANGER |
LU-139 | - | Growth Inhibition Assay | - | IC50=0.04442 μM | SANGER |
LU-165 | - | Growth Inhibition Assay | - | IC50=1.86476 μM | SANGER |
LU-65 | - | Growth Inhibition Assay | - | IC50=4.93033 μM | SANGER |
LXF-289 | - | Growth Inhibition Assay | - | IC50=0.0177 μM | SANGER |
MC116 | - | Growth Inhibition Assay | - | IC50=0.16158 μM | SANGER |
MC-CAR | - | Growth Inhibition Assay | - | IC50=3.54817 μM | SANGER |
MCF10A | 1/5/10 nM | Apoptosis Assay | 24/48/72 h | induces apoptosis in a dose-dependent manner | 23144294 |
MCF7 | - | Growth Inhibition Assay | - | IC50=5.11 ± 1.47 nM | 23962445 |
MCF7 | 100 nM | Function Assay | 1 h | reduces the induction of Greb1, Sgk1, Ps2, Serpina3, and Wisp2 | 23770244 |
MCF7 | 0-100 nM | Growth Inhibition Assay | 72 h | inhibits the cell viability in a dose-dependent mannar | 22309939 |
MCF7-FLV1000 | - | Growth Inhibition Assay | - | IC50=393.18 ± 74.83 nM | 23962445 |
MDA-MB-134-VI | - | Growth Inhibition Assay | - | IC50=0.50921 μM | SANGER |
MDA-MB-231 | 0-100 nM | Growth Inhibition Assay | 72 h | inhibits the cell viability in a dose-dependent mannar | 22309939 |
MDA-MB-468 | 1/5/10 nM | Apoptosis Assay | 24/48/72 h | induces apoptosis in a dose-dependent manner | 23144294 |
MDR19-HEK293 | - | Growth Inhibition Assay | - | IC50=85.50 ± 13.67 nM | 23962445 |
MEG-01 | - | Growth Inhibition Assay | - | IC50=0.25673 μM | SANGER |
MFH-ino | - | Growth Inhibition Assay | - | IC50=0.05003 μM | SANGER |
MFM-223 | - | Growth Inhibition Assay | - | IC50=10.9927 μM | SANGER |
MHH-CALL-2 | - | Growth Inhibition Assay | - | IC50=6.51508 μM | SANGER |
MHH-NB-11 | - | Growth Inhibition Assay | - | IC50=0.63801 μM | SANGER |
MHH-PREB-1 | - | Growth Inhibition Assay | - | IC50=0.06319 μM | SANGER |
ML-2 | - | Growth Inhibition Assay | - | IC50=0.05414 μM | SANGER |
MLMA | - | Growth Inhibition Assay | - | IC50=0.14167 μM | SANGER |
MMAC-SF | - | Growth Inhibition Assay | - | IC50=2.86628 μM | SANGER |
MN-60 | - | Growth Inhibition Assay | - | IC50=2.17308 μM | SANGER |
MOLT-13 | - | Growth Inhibition Assay | - | IC50=0.04238 μM | SANGER |
MOLT-16 | - | Growth Inhibition Assay | - | IC50=0.08121 μM | SANGER |
MOLT-4 | - | Growth Inhibition Assay | - | IC50=0.08983 μM | SANGER |
MOLT-4 | - | Growth Inhibition Assay | 24 h | IC50=2853.5 nM | 24519995 |
MOLT-4 | - | Growth Inhibition Assay | 48 h | IC50=26.6 nM | 24519995 |
MOLT-4 | - | Growth Inhibition Assay | 72 h | IC50=7.39 nM | 24519995 |
MONO-MAC-6 | - | Growth Inhibition Assay | - | IC50=0.07986 μM | SANGER |
Mo-T | - | Growth Inhibition Assay | - | IC50=17.4029 μM | SANGER |
MPP-89 | - | Growth Inhibition Assay | - | IC50=0.75978 μM | SANGER |
MRK-nu-1 | - | Growth Inhibition Assay | - | IC50=0.42205 μM | SANGER |
MRP1-HEK293 | - | Growth Inhibition Assay | - | IC50=2.99 ± 1.49 nM | 23962445 |
MS-1 | - | Growth Inhibition Assay | - | IC50=0.04701 μM | SANGER |
MSTO-211H | - | Growth Inhibition Assay | - | IC50=21.8858 μM | SANGER |
MV-4-11 | - | Growth Inhibition Assay | - | IC50=0.30788 μM | SANGER |
MZ1-PC | - | Growth Inhibition Assay | - | IC50=0.04127 μM | SANGER |
MZ2-MEL | - | Growth Inhibition Assay | - | IC50=0.1105 μM | SANGER |
MZ7-mel | - | Growth Inhibition Assay | - | IC50=0.12237 μM | SANGER |
Mz-ChA-2 | - | Growth Inhibition Assay | 72 h | IC50=3.31 nM | 21965739 |
NALM-16 | - | Growth Inhibition Assay | 24 h | IC50=96.28 nM | 24519995 |
NALM-16 | - | Growth Inhibition Assay | 48 h | IC50=63.24 nM | 24519995 |
NALM-16 | - | Growth Inhibition Assay | 72 h | IC50=77.73 nM | 24519995 |
NALM-6 | - | Growth Inhibition Assay | - | IC50=0.05973 μM | SANGER |
NALM-6 | - | Growth Inhibition Assay | 24 h | IC50=34330 nM | 24519995 |
NALM-6 | - | Growth Inhibition Assay | 48 h | IC50=23.26 nM | 24519995 |
NALM-6 | - | Growth Inhibition Assay | 72 h | IC50=1.78 nM | 24519995 |
NB1 | - | Growth Inhibition Assay | - | IC50=0.06613 μM | SANGER |
NB10 | - | Growth Inhibition Assay | - | IC50=30.2694 μM | SANGER |
NB13 | - | Growth Inhibition Assay | - | IC50=0.03316 μM | SANGER |
NB14 | - | Growth Inhibition Assay | - | IC50=5.97135 μM | SANGER |
NB17 | - | Growth Inhibition Assay | - | IC50=0.05207 μM | SANGER |
NB5 | - | Growth Inhibition Assay | - | IC50=0.15462 μM | SANGER |
NB6 | - | Growth Inhibition Assay | - | IC50=0.18566 μM | SANGER |
NB69 | - | Growth Inhibition Assay | - | IC50=1.26148 μM | SANGER |
NB7 | - | Growth Inhibition Assay | - | IC50=17.7467 μM | SANGER |
NCCIT | - | Growth Inhibition Assay | - | IC50=0.13939 μM | SANGER |
NCI-ADR-RES | - | Growth Inhibition Assay | - | IC50=1273.30 ± 191.20 nM | 23962445 |
NCI-H1092 | - | Growth Inhibition Assay | - | IC50=1.76182 μM | SANGER |
NCI-H1155 | - | Growth Inhibition Assay | - | IC50=1.73676 μM | SANGER |
NCI-H1304 | - | Growth Inhibition Assay | - | IC50=0.10594 μM | SANGER |
NCI-H1355 | - | Growth Inhibition Assay | - | IC50=0.02783 μM | SANGER |
NCI-H1395 | - | Growth Inhibition Assay | - | IC50=1.1067 μM | SANGER |
NCI-H1417 | - | Growth Inhibition Assay | - | IC50=0.53435 μM | SANGER |
NCI-H1436 | - | Growth Inhibition Assay | - | IC50=0.21464 μM | SANGER |
NCI-H1522 | - | Growth Inhibition Assay | - | IC50=0.59383 μM | SANGER |
NCI-H1581 | - | Growth Inhibition Assay | - | IC50=0.07478 μM | SANGER |
NCI-H1648 | - | Growth Inhibition Assay | - | IC50=0.02647 μM | SANGER |
NCI-H1650 | - | Growth Inhibition Assay | - | IC50=16.3765 μM | SANGER |
NCI-H1694 | - | Growth Inhibition Assay | - | IC50=0.08744 μM | SANGER |
NCI-H1770 | - | Growth Inhibition Assay | - | IC50=6.66904 μM | SANGER |
NCI-H1838 | - | Growth Inhibition Assay | - | IC50=38.3797 μM | SANGER |
NCI-H187 | - | Growth Inhibition Assay | - | IC50=0.07726 μM | SANGER |
NCI-H1882 | - | Growth Inhibition Assay | - | IC50=0.09809 μM | SANGER |
NCI-H1963 | - | Growth Inhibition Assay | - | IC50=0.01673 μM | SANGER |
NCI-H2081 | - | Growth Inhibition Assay | - | IC50=0.58611 μM | SANGER |
NCI-H209 | - | Growth Inhibition Assay | - | IC50=0.26374 μM | SANGER |
NCI-H2107 | - | Growth Inhibition Assay | - | IC50=1.01854 μM | SANGER |
NCI-H2126 | - | Growth Inhibition Assay | - | IC50=0.09791 μM | SANGER |
NCI-H2141 | - | Growth Inhibition Assay | - | IC50=0.19011 μM | SANGER |
NCI-H2171 | - | Growth Inhibition Assay | - | IC50=3.03448 μM | SANGER |
NCI-H2196 | - | Growth Inhibition Assay | - | IC50=0.97777 μM | SANGER |
NCI-H226 | - | Growth Inhibition Assay | - | IC50=4.33606 μM | SANGER |
NCI-H23 | - | Growth Inhibition Assay | - | IC50=2.80791 μM | SANGER |
NCI-H322M | - | Growth Inhibition Assay | - | IC50=42.5984 μM | SANGER |
NCI-H345 | - | Growth Inhibition Assay | - | IC50=0.23805 μM | SANGER |
NCI-H446 | - | Growth Inhibition Assay | - | IC50=0.09462 μM | SANGER |
NCI-H510A | - | Growth Inhibition Assay | - | IC50=0.08336 μM | SANGER |
NCI-H524 | - | Growth Inhibition Assay | - | IC50=0.11274 μM | SANGER |
NCI-H526 | - | Growth Inhibition Assay | - | IC50=0.1044 μM | SANGER |
NCI-H64 | - | Growth Inhibition Assay | - | IC50=0.16347 μM | SANGER |
NCI-H69 | - | Growth Inhibition Assay | - | IC50=0.64879 μM | SANGER |
NCI-H719 | - | Growth Inhibition Assay | - | IC50=3.30384 μM | SANGER |
NCI-H720 | - | Growth Inhibition Assay | - | IC50=0.20525 μM | SANGER |
NCI-H747 | - | Growth Inhibition Assay | - | IC50=0.137 μM | SANGER |
NCI-H748 | - | Growth Inhibition Assay | - | IC50=0.912 μM | SANGER |
NCI-H82 | - | Growth Inhibition Assay | - | IC50=0.03343 μM | SANGER |
NCI-H889 | - | Growth Inhibition Assay | - | IC50=0.59844 μM | SANGER |
NCI-SNU-1 | - | Growth Inhibition Assay | - | IC50=4.21999 μM | SANGER |
NCI-SNU-16 | - | Growth Inhibition Assay | - | IC50=0.10742 μM | SANGER |
NCI-SNU-5 | - | Growth Inhibition Assay | - | IC50=0.09258 μM | SANGER |
NEC | - | Growth Inhibition Assay | 72 h | IC50=9.98 nM | 21965739 |
NEC8 | - | Growth Inhibition Assay | - | IC50=0.10525 μM | SANGER |
NH-12 | - | Growth Inhibition Assay | - | IC50=33.2017 μM | SANGER |
NIH3T3 | - | Growth Inhibition Assay | - | IC50=40.60 ± 4.97 nM | 23962445 |
NIH3T3-G185 | - | Growth Inhibition Assay | - | IC50=2413.40 ± 423.66 nM | 23962445 |
NKM-1 | - | Growth Inhibition Assay | - | IC50=0.14906 μM | SANGER |
NMC-G1 | - | Growth Inhibition Assay | - | IC50=0.28217 μM | SANGER |
no-10 | - | Growth Inhibition Assay | - | IC50=0.05474 μM | SANGER |
no-11 | - | Growth Inhibition Assay | - | IC50=0.12869 μM | SANGER |
NOMO-1 | - | Growth Inhibition Assay | - | IC50=0.4386 μM | SANGER |
NOS-1 | - | Growth Inhibition Assay | - | IC50=0.02093 μM | SANGER |
NTERA-S-cl-D1 | - | Growth Inhibition Assay | - | IC50=0.03399 μM | SANGER |
OCI-AML2 | - | Growth Inhibition Assay | - | IC50=4.5523 μM | SANGER |
OCUB-M | - | Growth Inhibition Assay | - | IC50=0.01826 μM | SANGER |
OCUT-1 | 0.1-100 nM | Growth Inhibition Assay | 72 h | EC50=2.3 nM | 19223553 |
OMC-1 | - | Growth Inhibition Assay | - | IC50=0.96373 μM | SANGER |
ONS-76 | - | Growth Inhibition Assay | - | IC50=0.09276 μM | SANGER |
ONS-76 | 1.875-240 nM | Growth Inhibition Assay | 72 h | IC50=7.5 nM | 22390279 |
OPM-2 | - | Growth Inhibition Assay | - | IC50=0.23882 μM | SANGER |
OS-RC-2 | - | Growth Inhibition Assay | - | IC50=0.35544 μM | SANGER |
OVCAR-4 | - | Growth Inhibition Assay | - | IC50=0.04059 μM | SANGER |
OVCAR-8 | - | Growth Inhibition Assay | - | IC50=7.19 ± 3.60 nM | 23962445 |
P12 | - | Growth Inhibition Assay | 24 h | IC50=39.27 nM | 24519995 |
P12 | - | Growth Inhibition Assay | 48 h | IC50=18.46 nM | 24519995 |
P12 | - | Growth Inhibition Assay | 72 h | IC50=6.37 nM | 24519995 |
P30-OHK | - | Growth Inhibition Assay | - | IC50=7.21906 μM | SANGER |
PC3 | - | Growth Inhibition Assay | - | IC50∼175 nM | 23884428 |
pcDNA-HEK293 | - | Growth Inhibition Assay | - | IC50=2.75 ± 0.67 nM | 23962445 |
PF-382 | - | Growth Inhibition Assay | - | IC50=0.04198 μM | SANGER |
PSN1 | - | Growth Inhibition Assay | - | IC50=0.00776 μM | SANGER |
QIMR-WIL | - | Growth Inhibition Assay | - | IC50=0.27155 μM | SANGER |
R482-HEK293 | - | Growth Inhibition Assay | - | IC50=25.97 ± 4.95 nM | 23962445 |
Raji | - | Growth Inhibition Assay | - | IC50=0.74989 μM | SANGER |
Ramos-2G6-4C10 | - | Growth Inhibition Assay | - | IC50=0.08225 μM | SANGER |
RCC10RGB | - | Growth Inhibition Assay | - | IC50=8.0628 μM | SANGER |
REB | - | Growth Inhibition Assay | 72 h | IC50=13.51 nM | 21965739 |
REH | - | Growth Inhibition Assay | - | IC50=2.00582 μM | SANGER |
REH | - | Growth Inhibition Assay | 24 h | IC50=287.68 nM | 24519995 |
REH | - | Growth Inhibition Assay | 48 h | IC50=44.71 nM | 24519995 |
REH | - | Growth Inhibition Assay | 72 h | IC50=16.01 nM | 24519995 |
RH-1 | - | Growth Inhibition Assay | - | IC50=0.31871 μM | SANGER |
RKO | - | Growth Inhibition Assay | - | IC50=0.01987 μM | SANGER |
RL | - | Growth Inhibition Assay | - | IC50=39.2477 μM | SANGER |
RL95-2 | - | Growth Inhibition Assay | - | IC50=0.01738 μM | SANGER |
RPMI-6666 | - | Growth Inhibition Assay | - | IC50=0.12743 μM | SANGER |
RPMI-8226 | - | Growth Inhibition Assay | - | IC50=0.12052 μM | SANGER |
RPMI-8402 | - | Growth Inhibition Assay | - | IC50=0.02508 μM | SANGER |
RPMI-8866 | - | Growth Inhibition Assay | - | IC50=4.36029 μM | SANGER |
RS 4;11 | - | Growth Inhibition Assay | 24 h | IC50=519.05 nM | 24519995 |
RS 4;11 | - | Growth Inhibition Assay | 48 h | IC50=164.28 nM | 24519995 |
RS 4;11 | - | Growth Inhibition Assay | 72 h | IC50=4.38 nM | 24519995 |
RS4-11 | - | Growth Inhibition Assay | - | IC50=0.06304 μM | SANGER |
RT4 | - | Growth Inhibition Assay | - | IC50=27.21 nM | 23792639 |
RXF393 | - | Growth Inhibition Assay | - | IC50=0.06764 μM | SANGER |
S1 | - | Growth Inhibition Assay | - | IC50=24.30 ± 4.75 nM | 23962445 |
S1-M1-80 | - | Growth Inhibition Assay | - | IC50=261.06 ± 48.25 nM | 23962445 |
SBC-1 | - | Growth Inhibition Assay | - | IC50=0.265 μM | SANGER |
SCC-15 | - | Growth Inhibition Assay | - | IC50=2.2027 μM | SANGER |
SCC-3 | - | Growth Inhibition Assay | - | IC50=0.51873 μM | SANGER |
SCH | - | Growth Inhibition Assay | - | IC50=0.66023 μM | SANGER |
SCLC-21H | - | Growth Inhibition Assay | - | IC50=0.15702 μM | SANGER |
SF126 | - | Growth Inhibition Assay | - | IC50=0.25383 μM | SANGER |
SF188 | 10-100 nM | Growth Inhibition Assay | 24-96 h | inhibits cell growth in both time- and concentration- depedent manner | 23887645 |
SF268 | - | Growth Inhibition Assay | - | IC50=0.06286 μM | SANGER |
SF539 | - | Growth Inhibition Assay | - | IC50=0.48684 μM | SANGER |
SH-4 | - | Growth Inhibition Assay | - | IC50=0.15466 μM | SANGER |
SH-EP | 1-125 nM | Growth Inhibition Assay | 24-120 h | inhibits the cell proliferation in both time- and dose-dependent manne | 21169242 |
SHP-77 | - | Growth Inhibition Assay | - | IC50=0.70734 μM | SANGER |
SH-SY5Y | 1-125 nM | Growth Inhibition Assay | 24-120 h | inhibits the cell proliferation in both time- and dose-dependent manne | 21169242 |
SIG-M5 | - | Growth Inhibition Assay | - | IC50=0.22727 μM | SANGER |
SIL-ALL | - | Growth Inhibition Assay | 24 h | IC50=199.77 nM | 24519995 |
SIL-ALL | - | Growth Inhibition Assay | 48 h | IC50=74.62 nM | 24519995 |
SIL-ALL | - | Growth Inhibition Assay | 72 h | IC50=7.2 nM | 24519995 |
SIMA | - | Growth Inhibition Assay | - | IC50=3.58416 μM | SANGER |
SJSA-1 | - | Growth Inhibition Assay | - | IC50=0.0552 μM | SANGER |
Sk-ChA-1 | - | Growth Inhibition Assay | 72 h | IC50=17.2 nM | 21965739 |
SK-LMS-1 | - | Growth Inhibition Assay | - | IC50=0.05805 μM | SANGER |
SKM-1 | - | Growth Inhibition Assay | - | IC50=37.8422 μM | SANGER |
SK-MEL-1 | - | Growth Inhibition Assay | - | IC50=2.32047 μM | SANGER |
SK-MEL-2 | - | Growth Inhibition Assay | - | IC50=1.71789 μM | SANGER |
SK-MM-2 | - | Growth Inhibition Assay | - | IC50=0.43442 μM | SANGER |
SK-N-AS | 1-125 nM | Growth Inhibition Assay | 24-120 h | inhibits the cell proliferation in both time- and dose-dependent manne | 21169242 |
SK-N-BE | 1-125 nM | Growth Inhibition Assay | 24-120 h | inhibits the cell proliferation in both time- and dose-dependent manne | 21169242 |
SK-N-DZ | - | Growth Inhibition Assay | - | IC50=5.63465 μM | SANGER |
SK-NEP-1 | - | Growth Inhibition Assay | - | IC50=0.03499 μM | SANGER |
SK-N-FI | - | Growth Inhibition Assay | - | IC50=0.6391 μM | SANGER |
SK-PN-DW | - | Growth Inhibition Assay | - | IC50=0.12287 μM | SANGER |
SK-UT-1 | - | Growth Inhibition Assay | - | IC50=0.03774 μM | SANGER |
SN12C | 5-80 nM | Growth Inhibition Assay | 96 h | suppresses the proliferation in a dose-dependent manner with IC50 values of 2 to 20 nM | 21642374 |
SNB75 | - | Growth Inhibition Assay | - | IC50=0.18824 μM | SANGER |
SNU-C1 | - | Growth Inhibition Assay | - | IC50=2.21343 μM | SANGER |
SNU-C2B | - | Growth Inhibition Assay | - | IC50=0.01526 μM | SANGER |
SR | - | Growth Inhibition Assay | - | IC50=0.12441 μM | SANGER |
ST486 | - | Growth Inhibition Assay | - | IC50=0.03337 μM | SANGER |
SU-DHL-1 | - | Growth Inhibition Assay | - | IC50=0.16206 μM | SANGER |
SUM 149 | 0-100 nM | Growth Inhibition Assay | 72 h | inhibits the cell viability in a dose-dependent mannar | 22309939 |
SW1736 | 0.1-100 nM | Growth Inhibition Assay | 72 h | EC50=5.6 nM | 19223553 |
SW684 | - | Growth Inhibition Assay | - | IC50=0.30047 μM | SANGER |
SW872 | - | Growth Inhibition Assay | - | IC50=3.78101 μM | SANGER |
SW954 | - | Growth Inhibition Assay | - | IC50=0.01705 μM | SANGER |
SW962 | - | Growth Inhibition Assay | - | IC50=0.07839 μM | SANGER |
SW982 | - | Growth Inhibition Assay | - | IC50=0.0379 μM | SANGER |
T24 | - | Growth Inhibition Assay | - | IC50=79.12 nM | 23792639 |
T47D | 0-100 nM | Growth Inhibition Assay | 72 h | inhibits the cell viability in a dose-dependent mannar | 22309939 |
T98G | 10-100 nM | Growth Inhibition Assay | 24-96 h | inhibits cell growth in concentration- depedent manner | 23887645 |
TALL-1 | - | Growth Inhibition Assay | - | IC50=0.05708 μM | SANGER |
TE-1 | - | Growth Inhibition Assay | - | IC50=0.02512 μM | SANGER |
TE-10 | - | Growth Inhibition Assay | - | IC50=0.04046 μM | SANGER |
TE-11 | - | Growth Inhibition Assay | - | IC50=0.02809 μM | SANGER |
TE-12 | - | Growth Inhibition Assay | - | IC50=0.05613 μM | SANGER |
TE-15 | - | Growth Inhibition Assay | - | IC50=0.02738 μM | SANGER |
TE-441-T | - | Growth Inhibition Assay | - | IC50=0.5012 μM | SANGER |
TE-5 | - | Growth Inhibition Assay | - | IC50=0.05063 μM | SANGER |
TE-6 | - | Growth Inhibition Assay | - | IC50=0.05722 μM | SANGER |
TE-8 | - | Growth Inhibition Assay | - | IC50=0.00941 μM | SANGER |
TE-9 | - | Growth Inhibition Assay | - | IC50=0.02261 μM | SANGER |
TFK-1 | - | Growth Inhibition Assay | 72 h | IC50=13.45 nM | 21965739 |
TGBC1TKB | - | Growth Inhibition Assay | - | IC50=0.05405 μM | SANGER |
TGBC1-TKB | - | Growth Inhibition Assay | 144 h | IC50=6.72 nM | 21965739 |
TGBC24TKB | - | Growth Inhibition Assay | - | IC50=0.15659 μM | SANGER |
TGW | - | Growth Inhibition Assay | - | IC50=2.35027 μM | SANGER |
THP-1 | - | Growth Inhibition Assay | - | IC50=29.7201 μM | SANGER |
TK10 | - | Growth Inhibition Assay | - | IC50=0.11728 μM | SANGER |
TUR | - | Growth Inhibition Assay | - | IC50=41.6399 μM | SANGER |
U-266 | - | Growth Inhibition Assay | - | IC50=0.07497 μM | SANGER |
U-698-M | - | Growth Inhibition Assay | - | IC50=8.29226 μM | SANGER |
U-87-MG | - | Growth Inhibition Assay | - | IC50=25.1966 μM | SANGER |
U937 | 1/10/100 nM | Growth Inhibition Assay | 72 h | inhibits the cell proliferation in both time- and dose-dependent manne | 19458358 |
UACC-257 | - | Growth Inhibition Assay | - | IC50=0.19947 μM | SANGER |
VA-ES-BJ | - | Growth Inhibition Assay | - | IC50=0.07475 μM | SANGER |
WER-Rb-1 | 1-50 nM | Apoptosis Assay | 12/24 h | induced apoptosis which can be enhanced by HT | 24366665 |
Wittier | - | Growth Inhibition Assay | 72 h | IC50=3.26 nM | 21965739 |
Y79 | 1-50 nM | Apoptosis Assay | 12/24 h | induced apoptosis which can be enhanced by HT | 24366665 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00526149 | Breast Cancer ... more >> Endometrial Cancer Head and Neck Cancer Melanoma (Skin) Ovarian Cancer Sarcoma Collapse << | Phase 2 | Completed | - | Belgium ... more >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 Collapse << |
NCT00710710 | Pancreatic Neoplasms | Phase 2 | Completed | - | Austria ... more >> 1216.10.43001 Boehringer Ingelheim Investigational Site Wien, Austria Germany 1216.10.49013 Boehringer Ingelheim Investigational Site Celle, Germany 1216.10.49009 Boehringer Ingelheim Investigational Site Düsseldorf, Germany 1216.10.49007 Boehringer Ingelheim Investigational Site Essen, Germany 1216.10.49001 Boehringer Ingelheim Investigational Site Freiburg/Breisgau, Germany 1216.10.49005 Boehringer Ingelheim Investigational Site Hamburg, Germany 1216.10.49010 Boehringer Ingelheim Investigational Site Herne, Germany 1216.10.49008 Boehringer Ingelheim Investigational Site München, Germany 1216.10.49003 Boehringer Ingelheim Investigational Site Stuttgart, Germany 1216.10.49002 Boehringer Ingelheim Investigational Site Ulm, Germany Collapse << |
NCT00412880 | Carcinoma, Small Cell | Phase 2 | Completed | - | United States, Arkansas ... more >> 1216.11.007 Boehringer Ingelheim Investigational Site Fayetteville, Arkansas, United States United States, Illinois 1216.11.003 Boehringer Ingelheim Investigational Site Chicago, Illinois, United States 1216.11.006 Boehringer Ingelheim Investigational Site Evanston, Illinois, United States United States, Massachusetts 1216.11.002 Boehringer Ingelheim Investigational Site Boston, Massachusetts, United States United States, Missouri 1216.11.005 Boehringer Ingelheim Investigational Site St. Louis, Missouri, United States United States, North Carolina 1216.11.001 Boehringer Ingelheim Investigational Site Chapel Hill, North Carolina, United States United States, South Carolina 1216.11.011 Boehringer Ingelheim Investigational Site Charleston, South Carolina, United States 1216.11.010 Boehringer Ingelheim Investigational Site Greenville, South Carolina, United States United States, Washington 1216.11.012 Boehringer Ingelheim Investigational Site Seattle, Washington, United States Canada, Alberta 1216.11.009 Alberta Cancer Board Edmonton, Alberta, Canada Collapse << |
NCT00243087 | Lymphoma | Phase 1 | Completed | - | United States, District of Col... more >>umbia Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Nebraska UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-6805 United States, New York James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Texas M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 Collapse << |
NCT00706498 | Prostatic Neoplasms | Phase 2 | Completed | - | United Kingdom ... more >> 1216.19.4407 Boehringer Ingelheim Investigational Site Cambridge, United Kingdom 1216.19.4405 Boehringer Ingelheim Investigational Site Guildford, United Kingdom 1216.19.4402 Boehringer Ingelheim Investigational Site Headington, United Kingdom 1216.19.4406 The Christie NHS Foundation Trust Manchester, United Kingdom 1216.19.4404 Boehringer Ingelheim Investigational Site Newcastle Upon Tyne, United Kingdom 1216.19.4401 Boehringer Ingelheim Investigational Site Sutton, United Kingdom Collapse << |
NCT02215044 | Pancreatic Neoplasms | Phase 1 | Terminated | - | - |
NCT02211859 | Neoplasms | Phase 1 | Completed | - | - |
NCT00701766 | Leukemia, Myeloid, Acute | Phase 2 | Completed | - | Austria ... more >> 1216.20.43001 Boehringer Ingelheim Investigational Site Innsbruck, Austria 1216.20.43002 Boehringer Ingelheim Investigational Site Wien, Austria Germany 1216.20.49006 Boehringer Ingelheim Investigational Site Bonn, Germany 1216.20.49002 Boehringer Ingelheim Investigational Site Frankfurt, Germany 1216.20.49003 Boehringer Ingelheim Investigational Site Freiburg, Germany 1216.20.49004 Boehringer Ingelheim Investigational Site Hannover-Heideviertel, Germany 1216.20.49007 Boehringer Ingelheim Investigational Site Heidelberg, Germany 1216.20.49005 Boehringer Ingelheim Investigational Site Münster, Germany 1216.20.49001 Boehringer Ingelheim Investigational Site Ulm, Germany Collapse << |
NCT00376623 | Carcinoma, Non-Small-Cell Lung | Phase 2 | Completed | - | Germany ... more >> 1216.9.49002 Boehringer Ingelheim Investigational Site Freiburg, Germany 1216.9.49007 Boehringer Ingelheim Investigational Site Gauting, Germany 1216.9.49008 Boehringer Ingelheim Investigational Site Großhansdorf, Germany 1216.9.49001 Boehringer Ingelheim Investigational Site Heidelberg, Germany 1216.9.49004 Boehringer Ingelheim Investigational Site Mainz, Germany 1216.9.49005 Boehringer Ingelheim Investigational Site Mainz, Germany 1216.9.49003 Boehringer Ingelheim Investigational Site Wiesbaden, Germany Collapse << |
NCT02211872 | Neoplasms | Phase 1 | Completed | - | - |
NCT02211833 | Carcinoma, Non-Small-Cell Lung | Phase 1 | Completed | - | - |
靶点 | Description | IC50 |
---|---|---|
Bromodomain 4 | IC50:25nM | |
PLK1 | IC50:0.83nM |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网